# C_2008261EN.01001001.xml

| 14.10.2008 | EN | Official Journal of the European Union | C 261/10 |
| --- | --- | --- | --- |

14.10.2008

EN

Official Journal of the European Union

C 261/10

---

Prior notification of a concentration

(Case COMP/M.5264 — Invitrogen/Applied Biosystems)

(Text with EEA relevance)

(2008/C 261/08)

| 1. | On 7 October 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Invitrogen Corporation (‘Invitrogen’, United States of America) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Applied Biosystems Inc. (‘Applied Biosystems’, United States of America) by way of purchase of shares. |
| --- | --- |

1.

On 7 October 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Invitrogen Corporation (‘Invitrogen’, United States of America) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Applied Biosystems Inc. (‘Applied Biosystems’, United States of America) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | for Invitrogen: supply of reagents, sera, cell and tissue culture media for academic research, the life science industry and commercial markets, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Invitrogen: supply of reagents, sera, cell and tissue culture media for academic research, the life science industry and commercial markets,

| — | for Applied Biosystems: supply of instrument-based systems, consumables, software and services for academic research, the life science industry and commercial markets. |
| --- | --- |

—

for Applied Biosystems: supply of instrument-based systems, consumables, software and services for academic research, the life science industry and commercial markets.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5264 — Invitrogen/Applied Biosystems, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5264 — Invitrogen/Applied Biosystems, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---